Evidence map›Paper›PMID 17913920›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning.

Jennifer A Davis, Justin W Kenney, Thomas J Gould

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Nicotine effects on associative learning in human non-smokers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  3. Trial
  4. Increased Binding of [Synapse (New York, N.Y.) · 2026
    Article
  5. Article
  6. Reduction in [Brain research · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jennifer A DavisDepartment of Psychology, Neuroscience Program, Temple University, Philadelphia, Pennsylvania 19122, USA.
Justin W Kenney
Thomas J Gould
Temple University · US

Funding

TRAINING PROGRAM: DRUGS OF ABUSE RELATED NEUROPEPTIDEST32DA007237 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLEN M UNTERWALD · 1988 to 2026
$10.6M
Nicotine Addiction: Learning, Neural &Genetic ProcessR01DA017949 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI GOULD, THOMAS J · 2005 to 2015
$2.7M
Neural Substrates of Nicotine WithdrawalF31DA021949 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI MEIS, JENNIFER DAVIS · 2006 to 2006
$32k
NIDA NIH HHS DA017949NIDA NIH HHS DA021949NIDA NIH HHS F31 DA021949NIDA NIH HHS R01 DA017949NIDA NIH HHS T32 DA007237NIDA NIH HHS T32DA07237PHS HHS P5084718
6 · The paper itself

Abstract

Nicotine is known to enhance learning and memory in hippocampus-dependent tasks such as contextual fear conditioning. The present study was designed to directly examine whether the hippocampus plays a role in mediating this enhancement and which nicotinic acetylcholine receptor (nAChR) subtypes localized to the hippocampus are critical for enhanced learning. Contextual fear conditioning consisted of two white noise conditioned stimuli presentations, each coterminating with a 2 s, 0.57 mA footshock separated by a 120 s intertrial interval. Nicotine (0.09, 0.18, and 0.35 microg per side) was bilaterally infused into the dorsal hippocampus before training and testing. Infusions of nicotine into the dorsal hippocampus produced a dose-dependent enhancement of contextual fear conditioning. To determine which nAChRs are critical to the enhancing effect of nicotine, the preferential alpha4beta2 nAChR antagonist, dihydro-beta-erythroidine (DHbetaE) (6.00 and 18.00 microg per side), or the preferential alpha7 nAChR antagonist, methyllycaconitine (MLA) (13.50 and 27.00 microg per side), was bilaterally infused into the dorsal hippocampus before systemic injections of nicotine (0.09 mg/kg). DHbetaE infusions dose-dependently blocked the enhancement of contextual fear conditioning by nicotine, whereas MLA infusions yielded an intermediate effect. In addition, neither DHbetaE nor MLA had an effect on contextual fear conditioning in the absence of systemic nicotine. The present results suggest a critical role for alpha4beta2 nAChRs in the dorsal hippocampus for mediating the enhancing effect of nicotine on contextual fear conditioning.

Indexed as

AconitineAnalysis of VarianceAnimalsBehavior, AnimalConditioning, ClassicalDihydro-beta-ErythroidineDose-Response Relationship, DrugDrug InteractionsFearFemaleHippocampusMaleMiceMice, Inbred C57BLMice, KnockoutNicotineAconitineDihydro-beta-ErythroidinemethyllycaconitineNicotineNicotinic AgonistsNicotinic Antagonistsnicotinic receptor alpha4beta2Receptors, Nicotinic

Identifiers

PMID17913920
PMCPMC2705889
OpenAlexW2129666689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.